Determining therapeutic trough ranges for linezolid
Linezolid (LZD) is an oxazolidinone approved for the treatment of gram-positive infections. Therapeutic drug monitoring is increasingly used to optimize LZD dosing. The therapeutic target for LZD is to achieve an area under the concentration-time curve over 24 h divided by the MIC (AUC/MIC) > 100...
Saved in:
Main Author: | Abdullah Alsultan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dosage Strategy of Linezolid According to the Trough Concentration Target and Renal Function in Chinese Critically Ill Patients
by: Fan Wu, et al.
Published: (2022) -
Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis
by: Xiaoxi Liu, et al.
Published: (2022) -
Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections
by: Tzung-Yi Lee, et al.
Published: (2023) -
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
by: Bin Lin, et al.
Published: (2022) -
Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
by: Yi‐Chang Zhao, et al.
Published: (2021)